Literature DB >> 7492190

Size at birth and plasma insulin-like growth factor-1 concentrations.

C H Fall1, A N Pandit, C M Law, C S Yajnik, P M Clark, B Breier, C Osmond, A W Shiell, P D Gluckman, D J Barker.   

Abstract

OBJECTIVE: To test the hypothesis that reduced fetal growth leads to altered plasma insulin-like growth factor-1 (IGF-1) concentrations in childhood.
DESIGN: A follow up study of 4 year old children whose birth weights were recorded, and of 7 year old children whose weight, length, head circumference, and placental weight were measured at birth.
SETTING: Pune, India, and Salisbury, England.
SUBJECTS: 200 children born during October 1987 to April 1989 in the King Edward Memorial Hospital, Pune, weighing over 2.0 kg at birth and not requiring special care, and 244 children born during July 1984 to February 1985 in the Salisbury Health District and still living there. MAIN OUTCOME MEASURE: Plasma IGF-1 concentrations.
RESULTS: In both groups of children, and consistent with findings in other studies, plasma IGF-1 concentrations were higher in taller and heavier children, and higher in girls than boys. Allowing for sex and current size, concentrations were inversely related to birth weight (Pune p = 0.002; Salisbury p = 0.003). Thus at any level of weight or height, children of lower birth weight had higher IGF-1 concentrations. The highest concentrations were in children who were below average birth weight and above average weight or height when studied. Systolic blood pressures were higher in children with higher IGF-1 concentrations (Pune p = 0.01; Salisbury p = 0.04).
CONCLUSIONS: Children of lower birth weight develop higher circulating concentrations of IGF-1 than expected for their height and weight. This is consistent with the hypothesis that under-nutrition in utero leads to reprogramming of the IGF-1 axis. The increase of plasma IGF-1 concentrations in low birthweight children may also be linked to postnatal catch-up growth. High IGF-1 concentrations may be one of the mechanisms linking reduced fetal growth and high blood pressure in later life.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492190      PMCID: PMC1511321          DOI: 10.1136/adc.73.4.287

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  49 in total

1.  Somatomedin in cord blood: relationship to gestational age and birth size.

Authors:  P D Gluckman; M W Brinsmead
Journal:  J Clin Endocrinol Metab       Date:  1976-12       Impact factor: 5.958

2.  Serum somatomedin-C and bioassayable growth-promoting activity (thymidine activity) in appropriate and small-for-gestational-age human newborns.

Authors:  G Thiériot-Prévost; F Daffos; F Forestier
Journal:  Acta Endocrinol (Copenh)       Date:  1985-09

3.  A longitudinal study on plasma somatomedin activity in full-term, preterm and small-for-gestational age newborns.

Authors:  L Tatò; A Dal Moro; G Piemonte; V Vigi; P Pizzo; S Volpato; D Gaburro
Journal:  Biol Neonate       Date:  1981

4.  Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta.

Authors:  G L King; A D Goodman; S Buzney; A Moses; C R Kahn
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

5.  Somatomedin activity in human cord plasma and relationship to birth size, insulin, growth hormone, and prolactin.

Authors:  I K Ashton; J Vesey
Journal:  Early Hum Dev       Date:  1978-07       Impact factor: 2.079

6.  Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth.

Authors:  D J Barker; C N Hales; C H Fall; C Osmond; K Phipps; P M Clark
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

7.  Levels of insulin-like growth factors I and II in human cord blood.

Authors:  A Bennett; D M Wilson; F Liu; R Nagashima; R G Rosenfeld; R L Hintz
Journal:  J Clin Endocrinol Metab       Date:  1983-09       Impact factor: 5.958

8.  Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth.

Authors:  R M Bala; J Lopatka; A Leung; E McCoy; R G McArthur
Journal:  J Clin Endocrinol Metab       Date:  1981-03       Impact factor: 5.958

9.  Low somatomedin activity in cord serum from infants with intrauterine growth retardation.

Authors:  T P Foley; R DePhilip; A Perricelli; A Miller
Journal:  J Pediatr       Date:  1980-03       Impact factor: 4.406

10.  Heterogeneous growth and mental development of intrauterine growth-retarded infants during the first 3 years of life.

Authors:  J Villar; V Smeriglio; R Martorell; C H Brown; R E Klein
Journal:  Pediatrics       Date:  1984-11       Impact factor: 7.124

View more
  26 in total

1.  Birth weight and cognitive function in the British 1946 birth cohort: longitudinal population based study.

Authors:  M Richards; R Hardy; D Kuh; M E Wadsworth
Journal:  BMJ       Date:  2001-01-27

Review 2.  Maternal-placental-fetal interactions in the endocrine regulation of fetal growth: role of somatotrophic axes.

Authors:  Peter D Gluckman; Catherine S Pinal
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 3.  Maternal nutrition, fetal weight, body composition and disease in later life.

Authors:  Z Zadik
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 4.  Nutritional programming of disease: unravelling the mechanism.

Authors:  Simon C Langley-Evans
Journal:  J Anat       Date:  2008-10-14       Impact factor: 2.610

5.  Repeated betamethasone treatment of pregnant sheep programs persistent reductions in circulating IGF-I and IGF-binding proteins in progeny.

Authors:  Kathryn L Gatford; Julie A Owens; Shaofu Li; Timothy J M Moss; John P Newnham; John R G Challis; Deborah M Sloboda
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

Review 6.  Advances in endocrinology.

Authors:  P E Clayton; V Tillmann
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

7.  Early-life factors and breast cancer risk in Hispanic women: the role of adolescent body size.

Authors:  Meera Sangaramoorthy; Amanda I Phipps; Pamela L Horn-Ross; Jocelyn Koo; Esther M John
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-04       Impact factor: 4.254

Review 8.  Association between chronic undernutrition and hypertension.

Authors:  Ana L Sawaya; Ricardo Sesso; Telma M de Menezes Toledo Florêncio; Maria T B Fernandes; Paula A Martins
Journal:  Matern Child Nutr       Date:  2005-07       Impact factor: 3.092

9.  Birth weight and subsequent risk of cancer.

Authors:  Cassandra N Spracklen; Robert B Wallace; Shawnita Sealy-Jefferson; Jennifer G Robinson; Jo L Freudenheim; Melissa F Wellons; Audrey F Saftlas; Linda G Snetselaar; JoAnn E Manson; Lifang Hou; Lihong Qi; Rowan T Chlebowski; Kelli K Ryckman
Journal:  Cancer Epidemiol       Date:  2014-08-03       Impact factor: 2.984

Review 10.  Small for gestational age: towards 2004.

Authors:  Z Zadik; O Dimant; A Zung; R Reifen
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.